IVS3E4-14C_human-BCHE

General

Gene Locus : human-BCHE

Mode of mutation : Natural mutant

Disease :

Summary : Natural mutation I3E4-14C Silent phenotype, splicing defect Gatke_2007_Pharmacogenet.Genomics_17_995 || Natural mutant Probably no effect Parmo-Folloni_2008_Chem.Biol.Interact_175_135

AAA Change :

Allelic Variant :

Risk Factor :

Inhibitor :

Structure :

Disease by interaction :

Interact Gene Locus :

Xenobiotic sensitivity : Defect in Suxamethonium hydrolysis

Modification : Silent variant Natural mutation || Natural mutant

Torpedo_number : No torpedo number

Kinetic Parameter : No kinetic parameter

News : JUNE-18-2008

Comment : IVS3E4-14C I3E4-14C altered splicing between Intron 3 and exon 4, nt -14 at the acceptor site of intron 2, T>C found in cis with G115D(G143D) in a patient it is expected that this mutation does not alter splicing process

References (2)

Title : Two new mutations of the human BCHE gene (IVS3-14T>C and L574fsX576) - Parmo-Folloni_2008_Chem.Biol.Interact_175_135
Author(s) : Parmo-Folloni F , Nunes K , Lepienski LM , Mikami LR , de Souza RLR , Tsuneto LT , Petzl-Erler ML , Chautard-Freire-Maia EA
Ref : Chemico-Biological Interactions , 175 :135 , 2008
Abstract : Parmo-Folloni_2008_Chem.Biol.Interact_175_135
ESTHER : Parmo-Folloni_2008_Chem.Biol.Interact_175_135
PubMedSearch : Parmo-Folloni_2008_Chem.Biol.Interact_175_135
PubMedID: 18555211

Title : Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia - Gatke_2007_Pharmacogenet.Genomics_17_995
Author(s) : Gatke MR , Bundgaard JR , Viby-Mogensen J
Ref : Pharmacogenet Genomics , 17 :995 , 2007
Abstract : Gatke_2007_Pharmacogenet.Genomics_17_995
ESTHER : Gatke_2007_Pharmacogenet.Genomics_17_995
PubMedSearch : Gatke_2007_Pharmacogenet.Genomics_17_995
PubMedID: 18075469